Delirium of Mixed Origin
8
1
1
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
25.0%
2 terminated out of 8 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Trazodone vs. Quetiapine for the Treatment of ICU Delirium
Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care
Sight and Hearing Investigation Into Effects on Delirium
Music Therapy as a Treatment for Delirium in Acutely Hospitalized Older Patients
ZeroFall - Reliability Testing of Optical Sensor to Detect Bed Exit for Patients in Hospital
Estimation of Delirium Data Completeness
The Gut Microbiota and Delirium in the ICU
Delirium Prevention in Patients From the Intensive Care Unit (DELA)